Brain repair for Parkinson’s disease: is the answer in the matrix?

by Niamh Moriarty, Eilís Dowd
Published 2018-01-01

Central CB2 receptors in inflammation-driven neurodegeneration: dysregulation and therapeutic potential

by Ruth M Concannon, Eilís Dowd
Published 2016-01-01

Inhibition by Anandamide of 6-Hydroxydopamine-Induced Cell Death in PC12 Cells

by Katarzyna Mnich, David P. Finn, Eilis Dowd, Adrienne M. Gorman
Published 2010-01-01

Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease

by Rachel Kelly, Valerie Joers, Malú G. Tansey, Declan P. McKernan, Eilís Dowd
Published 2020-01-01